With regard to ovarian cancer, a very limited number of studies exist, reporting that targeted inhibition of ERRα hindered epithelial-to-mesenchymal transition and stem cell properties of ovarian cancer cells (Lam et al. 2014). This evidence concerns the gene ESRRA and ovarian cancer.